We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Okyo Pharma Limited | LSE:OKYO | London | Ordinary Share | GG00BD3FV870 | ORD NPV |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 91.00 | 1.20 | 1.60 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMWAFM
RNS Number : 8050D
West African Minerals Corporation
02 February 2018
2 February 2018
For immediate release
West African Minerals Corporation
("WAFM" or the "Company")
Change of name
Corporate update
Change of name effective
As previously announced, on 10 January 2018, Shareholders approved at the General Meeting the change of name of the Company to OKYO Pharma Corporation.
The Company announces that the name change has now become effective.
Accordingly, trading in the Company's Ordinary Shares on AIM under the name, OKYO Pharma Corporation, will commence at 8.00 a.m. on 5 February 2018 under a new ISIN, SEDOL and TIDM as set out below:
ISIN VGG6743A1093 ------ ------------- SEDOL BF1GCP0 ------ ------------- TIDM OKYO ------ -------------
The change of name will not affect any Shareholders' rights. New issues of Ordinary Share certificates will be in the new name of the Company. Existing Ordinary Share certificates will remain valid and it is not proposed that replacement Ordinary Share certificates be issued in the name of OKYO Pharma Corporation until required.
Further information is available on the Company's website: www.westafricanminerals.com. As from 5 February 2018, the Company's website will be: www.okyopharma.com
Special Dividend
The Disposal of the Company's interest in Ferrum by way of the Special Dividend was also approved at the General Meeting. The Company is currently finalising the arrangements for completion of the Special Dividend and the Board currently anticipates payments of the Special Dividend at the end of this month.
For further information contact:
West African Minerals Corporation Willy Simon +44 (0)20 7382 8300 Roland Cornish Beaumont Cornish Limited (Nominated Adviser) Michael Cornish +44 (0)20 7628 3396 Beaufort Securities Limited (Broker) Jon Belliss +44 (0)20 7382 8300
This announcement is inside information for the purposes of Article 7 of Regulation 596/2014. The person who arranged for the release of this announcement on behalf of the Company was Willy Simon, Director.
Forward-looking statements
Certain statements in this announcement constitute "forward-looking statements". Forward-looking statements include statements concerning the plans, objectives, goals, strategies and future operations and performance of the Company and the assumptions underlying these forward-looking statements. The Company uses the words "anticipates", "estimates", "expects", "believes", "intends", "plans", "may", "will", "should", and any similar expressions to identify forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause the Company's actual results, performances or achievements to be materially different from any future results, performances or achievements expressed or implied by such forward-looking statements. Such forward-looking statements are based on numerous assumptions regarding present and future business strategies and the environment in which the Company will operate in the future. These forward-looking statements speak only as at the date of this announcement. The Company is not obliged, and does not intend, to update or to revise any forward-looking statements, whether as a result of new information, future events or otherwise except to the extent required by any applicable law or regulation. All subsequent written or oral forward-looking statements attributable to the Company, or persons acting on behalf of the Company, are expressly qualified in their entirety by the cautionary statements contained throughout this announcement. As a result of these risks, uncertainties and assumptions, a prospective investor should not place undue reliance on these forward-looking statements.
APPENDIX
DEFINITIONS
In this announcement, the following expressions have the following meanings unless the context otherwise requires:
"AIM" the market of that name operated by the London Stock Exchange "Disposal" the proposed disposal of the Ferrum Shares by means of the Special Dividend "Ferrum" Ferrum Resources Limited, a wholly-owned subsidiary of WAFM "Ferrum Shares" the ordinary shares of no par value in the capital of Ferrum "General Meeting" the meeting of the Shareholders held on 10 January 2018 "London Stock the London Stock Exchange plc Exchange" "Ordinary Shares" ordinary shares of no par value in the capital of the Company "Shareholders" holders of Ordinary Shares "Special Dividend" the distribution of Ferrum Shares to Shareholders on the record date (being the close of business on10 January 2018). "WAFM" or "the West African Minerals Corporation, Company" a company incorporated in the British Virgin Islands with registered number 1415559
ENDS
This information is provided by RNS
The company news service from the London Stock Exchange
END
CANXLLFBVLFFBBX
(END) Dow Jones Newswires
February 02, 2018 08:17 ET (13:17 GMT)
1 Year Okyo Pharma Chart |
1 Month Okyo Pharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions